The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging
Open accessAbstract
IMPORTANCE: Peripheral glucose homeostasis has been implicated in the pathogenesis of Alzheimer disease (AD). The relationship among diabetes mellitus, insulin, and AD is an important area of investigation. However, whether cognitive impairment seen in those with diabetes is mediated by excess pathological features of AD or other related abnormalities, such as vascular disease, remains unclear. OBJECTIVE: To investigate the association between serial measures of glucose intolerance and insulin resistance and in vivo brain β-amyloid burden, measured with carbon 11–labeled Pittsburgh Compound B (11C-PiB), and AD pathology at autopsy. DESIGN: Scores calculated from the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) and Braak criteria were correlated with measures of hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance in 197 participants who underwent autopsy after death and who had undergone 2 or more oral glucose tolerance tests (OGTT) using grouped analyses and a continuous mixed-models analysis. The same measures of glucose intolerance and insulin resistance were also correlated with brain 11C-PiB retention in an additional 53 living subjects from the Baltimore Longitudinal Study of Aging neuroimaging study. SETTING: Prospective, serially assessed cohort of community-dwelling subjects. PARTICIPANTS: Cohort 1 consisted of 197 participants enrolled in the Baltimore Longitudinal Study of Aging who had 2 or more OGTTs during life and a complete brain autopsy after death. Cohort 2 consisted of 53 living subjects who had 2 or more OGTTs and underwent brain 11C-PiB positron emission tomography. EXPOSURES: Autopsy and 11C-PiB positron emission tomography. MAIN OUTCOMES AND MEASURES: The correlation of brain markers of AD, including CERAD score, Braak score, and 11C-PiB retention, with serum markers of glucose homeostasis using grouped and continuous mixed-models analyses. RESULTS: We found no significant correlations between measures of brain AD pathology or 11C-PiB β-amyloid load and glucose intolerance or insulin resistance in subjects who had a mean (SD) of 6.4 (3.2) OGTTs during 22.1 (8.0) years of follow-up. Thirty subjects with frank diabetes mellitus who received medications also had AD pathology scores that were similar to those of the cohort as a whole. CONCLUSIONS AND RELEVANCE: In this prospective cohort with multiple assessments of glucose intolerance and insulin resistance, measures of glucose and insulin homeostasis are not associated with AD pathology and likely play little role in AD pathogenesis. Long-term therapeutic trials are important to elucidate this issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many studies have failed to establish a relationship between systemic insulin resistance or type 2 diabetes and molecular symptoms of neurodegenerative diseases 142”
From Intranasal insulin (2021) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Self-citationLinear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Self-citationTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Cited by
Sorted by citations
Items 101–155 of 155
Hanson, A. J., Banks, W. A., Saucedo, H. H., & Craft, S. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000444079 · Cited by 18
Cognitive resilience among APOE ε4 carriers in the oldest old
Hayden, K. M., Gaussoin, S. A., Hunter, J. C., Manson, J. E., Sachs, B. C., Shadyab, A. H., Tindle, H. A., Mossavar‐Rahmani, Y., Mozhui, K., Snively, B. M., et al. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5199 · Cited by 17
Self-citationAli, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Bahaa, M. M., Al-Ibrahim, F., & Batiha, G. E. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70118 · Cited by 17
Rantanen, K. K., Strandberg, A. Y., Salomaa, V. V., Pitkälä, K. H., Tilvis, R. S., Tienari, P. J., & Strandberg, T. E. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1290821 · Cited by 16
Philippou, E., Michaelides, M. P., & Constantinidou, F. (2018) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2018.1483487 · Cited by 16
van Gils, V., Tao, Q., Ang, T. F. A., Young, C. B., Mormino, E. C., Qiu, W. Q., Visser, P. J., Au, R., Jansen, W. J., & Vos, S. J. B. (2024) · Diabetes Care · doi:10.2337/dc24-0162 · Cited by 17
Cognitive impairment is correlated with insulin resistance degree: the “PA-NICO-study”
Fava, A., Colica, C., Plastino, M., Messina, D., Cristiano, D., Opipari, C., Vaccaro, A., Gorgone, G., Bosco, F., Fratto, A., et al. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-9977-4 · Cited by 17
New Horizons—Cognitive Dysfunction Associated With Type 2 Diabetes
Moran, C., Than, S., Callisaya, M. L., Beare, R. J., & Srikanth, V. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab797 · Cited by 15
Shwe, T., Bo‐Htay, C., Leech, T., Ongnok, B., Jaiwongkum, T., Kerdphoo, S., Palee, S., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111001 · Cited by 13
Tracking the potential involvement of metabolic disease in Alzheimer's disease—Biomarkers and beyond
Luchsinger, J. A., & Zetterberg, H. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.014 · Cited by 13
Pietilä, E. M., Snellman, A., Tuisku, J., Helin, S., Viitanen, M. H., Jula, A., Rinne, J. O., & Ekblad, L. L. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106385 · Cited by 12
Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240495 · Cited by 11
Brogan, R. J., Rooyackers, O., Phillips, B. E., Twelkmeyer, B., Ross, L. M., Atherton, P. J., Kraus, W. E., Timmons, J. A., & Gallagher, I. J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf285 · Cited by 10
Proitsi, P., Lupton, M. K., Velayudhan, L., Hunter, G., Newhouse, S., Lin, K., Fogh, I., Tsolaki, M., Daniilidou, M., Pritchard, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.023 · Cited by 10
Ennis, G. E., Koscik, R. L., Ma, Y., Jonaitis, E. M., Hulle, C. A. V., Betthauser, T. J., Randall, A. M., Chin, N. A., Engelman, C. D., Anderson, R. M., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12220 · Cited by 10
Type 2 diabetes has a slow and insidious effect on cognition
Umegaki, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.17 · Cited by 9
Impaired glycemia and Alzheimer's disease
Morris, J. K., Vidoni, E. D., Honea, R. A., & Burns, J. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.018 · Cited by 9
Rosness, T. A., Engedal, K., Bjertness, E., & Strand, B. H. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13870 · Cited by 8
Thambisetty, M. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00111.2017 · Cited by 8
Self-citationNeuropathological links between T2DM and LOAD: systematic review and meta-analysis
Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 9
Impaired glycemia and Alzheimer's disease
Umegaki, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.017 · Cited by 7
Yu, F., Pituch, K. A., Maxfield, M., Baena, E., Geda, Y. E., Pruzin, J. J., Coon, D. W., Shaibi, G. Q., & HABS-HD Study Team (2024) · PLoS ONE · doi:10.1371/journal.pone.0295749 · Cited by 6
Ennis, G. E., Kohli, A., Jonaitis, E. M., Betthauser, T. J., Oh, J. M., Taylor, C. E., Chin, N. A., Koscik, R. L., Christian, B. T., Asthana, S., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.028 · Cited by 6
Kim, K. Y., Kim, E., Lee, J., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01564-y · Cited by 5
Lee, T. H.-Y., Hurwitz, E. L., Cooney, R. V., Wu, Y. Y., Wang, C., Masaki, K., & Grandinetti, A. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.06.031 · Cited by 6
Cognitive Dysfunction in Diabetes Mellitus
Biessels, G. J., & Ryan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00088-2 · Cited by 6
Plasma Insulin Predicts Early Amyloid-β Pathology Changes in Alzheimer’s Disease
Chen, Y., Initiative, A. D. N., Wang, Z.-B., Liu, X., & Mao, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240289 · Cited by 4
Hugenschmidt, C. E. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0093-2 · Cited by 4
Toppala, S., Ekblad, L. L., Viitanen, M. H., Rinne, J. O., & Jula, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220894 · Cited by 3
Albajy, M. A., & Mihailescu, D. F. (2024) · Health Problems of Civilization · doi:10.5114/hpc.2024.136467 · Cited by 2
Erbguth, F. J. (2015) · Der Diabetologe · doi:10.1007/s11428-015-1341-x · Cited by 2
Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype
Sung, J. H., Ou, Y., & Barger, S. W. (2023) · eNeuro · doi:10.1523/eneuro.0376-22.2023 · Cited by 2
Hsiao, Y.-C., Yang, Y., Liu, C., Peng, J., Feng, J., Zhao, H., Teitelbaum, T., & Lü, K. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00475 · Cited by 2
Diabetes and brain health: implications for practice
Dolan, C., Power, J. M., & LAWLOR, B. A. (2015) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2015.55 · Cited by 2
Kumazoe, M., Tomioka, R., Murata, K., Nishioka, S., Goto, M., Kobarai, H., Yoshitomi, R., Marugame, Y., Iwasaki, T., Takaki, K., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c09761 · Cited by 1
Brain Imaging in Type 2 Diabetes
Moran, C., Beare, R. J., Phan, T. G., & Srikanth, V. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00004-4 · Cited by 1
Neuropathological Insights Into the Link Between Type 2 Diabetes and Dementia
Pruzin, J. J., Nelson, P. T., Abner, E. L., & Arvanitakis, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00006-8 · Cited by 1
Should Renal Function Become an Important Factor in Cognitive Impairment and Cognitive Decline?
Li, M., & Tang, Z. (2014) · Medical Principles and Practice · doi:10.1159/000362795
Marder, T. J., Flores, V. L., Bolo, N. R., Hoogenboom, W. S., Simonson, D. C., Jacobson, A. M., Foote, S., Shenton, M. E., Reisa, A., Musen, G., et al. (2014)
Exenatide as a novel treatment for Parkinson's Disease
Avilés-Olmos, I. (2013) · UCL Discovery (University College London)
The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
Verdile, G., Fraser, P. E., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch4
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732579862.793572336
Amyloid β-peptide impacts on glucose regulation are dependent on apolipoprotein E genotypePreprint
Sung, J. H., Ou, Y., & Barger, S. W. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.22.497222
TYPE II DIABETES MELLITUS AND MANAGEMENT OF ISOLATED HYPERGLYCEMIA: A REVIEW
TELLO, J. D. C., MORETTA, D. E. S., HERNÁNDEZ, G. J. V., & Medina, L. S. H. (2022) · Innovare Journal of Health Sciences · doi:10.22159/ijhs.2022.v10i1.44968
Metabolic Disorder Therapeutics and their Effects on Memory
Aggarwal, P., Khan, M. F., & Banerjee, S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273269329231013074613
Imerb, N., Pantiya, P., Thonusin, C., Chanpaisaeng, K., Chattipakorn, N., Charoenphandhu, N., & Chattipakorn, S. C. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0023
Kumar, P., Lele, V. R., & Akhtar, M. J. (2025) · Cureus · doi:10.7759/cureus.89682
Kim, K. Y., Kim, E., & Lee, J.-Y. (2024) · Figshare · doi:10.6084/m9.figshare.27012147
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Figshare · doi:10.6084/m9.figshare.22618903
Frison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847
Physical activity and metabolic syndrome in relation to incident dementia in UK biobank
Li, Y., Ren, X., Jiang, M., Yang, P., Jia, Y., Sun, L., Wang, R., Shi, M., Zheng, X., Zhu, Z., et al. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-025-01058-0
Imbimbo, B. P., Pomara, N., Pini, L., & Frederiksen, K. S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119943
Besondere Situationen bei Diabetes mellitus
Blüher, M., Druml, W., Ehren, M., Hummel, M., Kopf, D., Müssig, K., Pfohl, M., & Schifferdecker, E. (2014) · Springer eBooks · doi:10.1007/978-3-642-41358-2_9
Metadata
- Authors
- Thambisetty, M., Metter, E. J., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., Troncoso, J. C., Zhou, Y., Wong, D. F., Ferrucci, L., Egan, J., Resnick, S. M., & O’Brien, R. J.
- Affiliations
- National Institute on Aging (US)
- Johns Hopkins University (US)
- Corresponding author
- O’Brien, Richard J.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-09-01
- Volume
- 70
- Issue
- 9
- Pages
- 1167
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC3934653
- OpenAlex
- W2160143874
- Cited by
- 155
- References
- 37
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 13 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 14 · 2019: 9 · 2018: 11 · 2017: 20 · 2016: 11 · 2015: 17 · 2014: 19 · 2013: 4
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (U19AG033655, U01AG033655, P50AG005146, P50AG05146)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Alzheimer's disease, impaired glucose tolerance, insulin resistance, diabetes mellitus, hyperinsulinemia, hyperglycemia, brain amyloid burden, 11C-PiB PET, autopsy neuropathology, glucose homeostasis, oral glucose tolerance test, Baltimore Longitudinal Study of Aging, vascular disease, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Aniline Compounds, Cognition Disorders, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Prospective Studies, Radionuclide Imaging, Thiazoles, Baltimore, Glucose Intolerance, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
